Tomić Krešimir, Tica Sedlar Ivana, Berić Jozić Gordana, Marijanović Inga, Lukić Blanka, Miletić Dragana, Puljić Ćuk Ana
Clinic of Oncology, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina.
Acta Med Acad. 2018 May;47(1):82-87. doi: 10.5644/ama2006-124.217.
We present a patient with metastatic melanoma who had a complete response to second line chemotherapy with paclitaxel and carboplatin.
Metastatic melanoma is an aggressive cancer with poor prognosis and 10 year survival less than 10%. We present a patient with metastatic melanoma who had a complete response to second line chemotherapy with paclitaxel and carboplatin.
Second line chemotherapy with paclitaxel and carboplatin in the treatment of metastatic melanoma may yield effective results.